Evidence map›Paper›PMID 38142410›Full record

ArticleBlood2024

Clearance of VWF by hepatic macrophages is critical for the protective effect of ADAMTS13 in sickle cell anemia mice.

Huiping Shi, Liang Gao, Nicole Kirby, Bojing Shao, Xindi Shan, Mariko Kudo, Robert Silasi, John Michael McDaniel, Meixiang Zhou, Samuel McGee and 5 more

Abstract read
In one paragraph

Article in Blood, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Mouse models to study von Willebrand factor in thrombosis: a scoping review.Research and practice in thrombosis and haemostasis · 2026
    Article
  2. Review
  3. Macrophages in Hematopoiesis and Related Blood Diseases.Genomics, proteomics & bioinformatics · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Huiping ShiCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.ORCID 0000-0002-4727-9999
Liang GaoCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.ORCID 0009-0008-8073-1079
Nicole KirbyCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.ORCID 0009-0007-8923-8144
Bojing ShaoCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.
Xindi ShanCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.
Mariko KudoCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.ORCID 0009-0004-2919-3624
Robert SilasiCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.ORCID 0000-0001-9590-6160
John Michael McDanielCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.
Meixiang ZhouCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.
Samuel McGeeCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.
Wei JingCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.
Florea LupuCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.ORCID 0000-0003-1249-9278
Audrey CleurenCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.ORCID 0000-0003-1384-4651
James N GeorgeHematology-Oncology Section, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK.ORCID 0000-0002-4243-2691
Lijun XiaCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.ORCID 0000-0002-9586-7971
Oklahoma Medical Research Foundation · USUniversity of Oklahoma Health Sciences Center · US

Funding

Platelet CLEC-2 in Arterial ThrombosisR01HL149860 · NHLBI · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI XIA, LIJUN · 2020 to 2023
$1.7M
Site-1 protease-mediated lipid metabolism in lymphatic vascular developmentR01HL153728 · NHLBI · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI XIA, LIJUN · 2020 to 2023
$1.7M
NHLBI NIH HHS R01 HL149860NHLBI NIH HHS R01 HL153728
6 · The paper itself

Abstract

abstractAlthough it is caused by a single-nucleotide mutation in the β-globin gene, sickle cell anemia (SCA) is a systemic disease with complex, incompletely elucidated pathologies. The mononuclear phagocyte system plays critical roles in SCA pathophysiology. However, how heterogeneous populations of hepatic macrophages contribute to SCA remains unclear. Using a combination of single-cell RNA sequencing and spatial transcriptomics via multiplexed error-robust fluorescence in situ hybridization, we identified distinct macrophage populations with diversified origins and biological functions in SCA mouse liver. We previously found that administering the von Willebrand factor (VWF)-cleaving protease ADAMTS13 alleviated vaso-occlusive episode in mice with SCA. Here, we discovered that the ADAMTS13-cleaved VWF was cleared from the circulation by a Clec4f+Marcohigh macrophage subset in a desialylation-dependent manner in the liver. In addition, sickle erythrocytes were phagocytized predominantly by Clec4f+Marcohigh macrophages. Depletion of macrophages not only abolished the protective effect of ADAMTS13 but exacerbated vaso-occlusive episode in mice with SCA. Furthermore, promoting macrophage-mediated VWF clearance reduced vaso-occlusion in SCA mice. Our study demonstrates that hepatic macrophages are important in the pathogenesis of SCA, and efficient clearance of VWF by hepatic macrophages is critical for the protective effect of ADAMTS13 in SCA mice.

Indexed as

Anemia, Sickle CellVascular DiseasesADAMTS13 ProteinAnimalsIn Situ Hybridization, FluorescenceMacrophagesMicevon Willebrand FactorADAMTS13 ProteinADAMTS13 protein, mousevon Willebrand Factor

Identifiers

PMID38142410
PMCPMC10997916
OpenAlexW4390166553

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.